Ajanta Pharma gets USFDA nod for Entacapone pills

Pharma major, Ajanta Pharma announced that the company has acquired the final approval from US FDA for Entacapone drugs. it is a bioequivalent typical version of Comtan 1 tablets.

Pharma main,Ajanta Pharma introduced that the corporate has acquired the final approval from USFDAfor Entacapone drugs. it's a bioequivalent general model of Comtan 1 drugs.

The company will be launching the product shortly in 200mg energy pills.The drug is a part of the rising portfolio of products that Ajanta has developed for the united states market.In whole, Ajanta has 35 Abbreviated New Drug application (ANDA) of which it has ultimate approvals for 20 ANDAs; tentative approvals for 2 ANDA; and thirteen ANDAs are under evaluation with US FDA.

Meanwhile, the stock was trading up by using 0.05% at Rs 1,201 per share on BSE at 0926 hours. It opened at Rs 1,211.10 per share. It touched its intraday excessive and low at Rs 1215,sixty five and Rs 1201.55 per share, respectively. The stock attracted a total traded quantity of 34,497 shares and traded price of Rs 417.58 lakh on NSE at 0931 hours. Its 52-week excessive stood at Rs 2,125 as on October 4, 2016 and 52-week low at Rs 1,135 as on August 22, 2017.

The Adviser Street is a leading Indian Financial Management firm that provides a wide range of financial services to a substantial and diversified client base that includes corporations, financial institutions and high-net-worth individuals.

Visit - Adviser Street

Contact - 8818888127